MENU
+Compare
RCEL
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$9.75
Change
-$0.20 (-2.01%)
Capitalization
399.48M

RCEL Avita Medical Forecast, Technical & Fundamental Analysis

a company, which engages in the development and distribution of regenerative and respiratory medicine and treatments

RCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for RCEL with price predictions
Feb 18, 2025

Momentum Indicator for RCEL turns positive, indicating new upward trend

RCEL saw its Momentum Indicator move above the 0 level on February 14, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 97 similar instances where the indicator turned positive. In of the 97 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where RCEL's RSI Oscillator exited the oversold zone, of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 69 cases where RCEL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for RCEL just turned positive on January 29, 2025. Looking at past instances where RCEL's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where RCEL advanced for three days, in of 287 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RCEL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RCEL broke above its upper Bollinger Band on February 14, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RCEL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.143) is normal, around the industry mean (23.499). P/E Ratio (0.000) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (7.849) is also within normal values, averaging (41.339).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RCEL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
RCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

RCEL is expected to report earnings to fall 24.52% to -33 cents per share on May 08

Avita Medical RCEL Stock Earnings Reports
Q1'25
Est.
$-0.33
Q4'24
Missed
by $0.10
Q3'24
Missed
by $0.19
Q2'24
Missed
by $0.12
Q1'24
Missed
by $0.41
The last earnings report on February 13 showed earnings per share of -43 cents, missing the estimate of -34 cents. With 259.71K shares outstanding, the current market capitalization sits at 399.48M.
A.I. Advisor
published General Information

General Information

a company, which engages in the development and distribution of regenerative and respiratory medicine and treatments

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
28159 Avenue Stanford
Phone
+1 833 462-8482
Employees
207
Web
https://www.avitamedical.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY611.491.79
+0.29%
SPDR® S&P 500® ETF Trust
AAPL244.47-0.13
-0.05%
Apple
GME26.97-0.03
-0.11%
GameStop Corp
BTC.X95539.550000-233.835940
-0.24%
Bitcoin cryptocurrency
TSLA354.11-1.73
-0.49%
Tesla

RCEL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RCEL has been loosely correlated with PHCCF. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if RCEL jumps, then PHCCF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCEL
1D Price
Change %
RCEL100%
-2.18%
PHCCF - RCEL
42%
Loosely correlated
N/A
INMD - RCEL
35%
Loosely correlated
+1.59%
DIZTF - RCEL
32%
Poorly correlated
N/A
MBOT - RCEL
29%
Poorly correlated
-3.52%
BLFS - RCEL
28%
Poorly correlated
+1.98%
More